Roger brings to the ad board broad experience in the pharmaceutical and medtech industries, including building and leading national sales, marketing and business support teams. Heading up Commercial Operations and Established brands at Organon, he leads all business support functions for the US Market with P&L responsibility for the late-lifecycle product portfolio. In the Organon spinoff from Merck in 2021, Roger served as the US Commercial Separation Lead.

In three prior Merck roles, Roger led the Established Products Business Unit, was National Sales Leader for the Respiratory, Neuroscience and Ophthalmic Sales Teams, and Executive Director for the Atherosclerosis Marketing team. Prior to that, he was an Area VP at Sherwood Davis & Geek, the medical device subsidiary of Wyeth.